Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:39 UTC |
---|
HMDB ID | HMDB0014549 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Dexbrompheniramine |
---|
Description | Dexbrompheniramine, also known as parabromdylamine or disophrol, belongs to the class of organic compounds known as pheniramines. Pheniramines are compounds containing a pheniramine moiety, which is structurally characterized by the presence of a 2-benzylpyridine linked to an dimethyl(propyl)amine to form a dimethyl[3-phenyl-3-(pyridin-2-yl)propyl]amine skeleton. Dexbrompheniramine is a histamine H1 antagonist (or more correctly, an inverse histamine agonist) of the alkylamine class. Signs of an overdose include fast or irregular heartbeat, mental or mood changes, tightness in the chest, and unusual tiredness or weakness. Dexbrompheniramine is a drug which is used for treatment and relief of symptoms of allergies, hay fever, and colds. Dexbrompheniramine is a very strong basic compound (based on its pKa). In humans, dexbrompheniramine is involved in brompheniramine h1-antihistamine action. In allergic reactions an allergen interacts with and cross-links surface IgE antibodies on mast cells and basophils. Once released, histamine can react with local or widespread tissues through histamine receptors. Histamine also increases vascular permeability and potentiates pain. |
---|
Structure | CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C1=CC=CC=N1 InChI=1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3/t15-/m0/s1 |
---|
Synonyms | Value | Source |
---|
(+)-Brompheniraminum | ChEBI | (S)-(+)-Brompheniramine | ChEBI | (S)-Brompheniramine | ChEBI | D-Brompheniramine | ChEBI | Dexbromfeniramina | ChEBI | Dexbrompheniraminum | ChEBI | Parabromdylamine | HMDB | Parabromodylamine | HMDB | Disophrol | HMDB | Dexbrompheniramine maleate | HMDB |
|
---|
Chemical Formula | C16H19BrN2 |
---|
Average Molecular Weight | 319.239 |
---|
Monoisotopic Molecular Weight | 318.073161265 |
---|
IUPAC Name | [(3S)-3-(4-bromophenyl)-3-(pyridin-2-yl)propyl]dimethylamine |
---|
Traditional Name | dexbrompheniramine |
---|
CAS Registry Number | 132-21-8 |
---|
SMILES | CN(C)CC[C@@H](C1=CC=C(Br)C=C1)C1=CC=CC=N1 |
---|
InChI Identifier | InChI=1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3/t15-/m0/s1 |
---|
InChI Key | ZDIGNSYAACHWNL-HNNXBMFYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pheniramines. Pheniramines are compounds containing a pheniramine moiety, which is structurally characterized by the presence of a 2-benzylpyridine linked to an dimethyl(propyl)amine to form a dimethyl[3-phenyl-3-(pyridin-2-yl)propyl]amine skeleton. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Pyridines and derivatives |
---|
Sub Class | Pheniramines |
---|
Direct Parent | Pheniramines |
---|
Alternative Parents | |
---|
Substituents | - Pheniramine
- Bromobenzene
- Halobenzene
- Aralkylamine
- Aryl bromide
- Benzenoid
- Monocyclic benzene moiety
- Aryl halide
- Heteroaromatic compound
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Organic nitrogen compound
- Organonitrogen compound
- Organobromide
- Organohalogen compound
- Amine
- Hydrocarbon derivative
- Organopnictogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.013 g/L | Not Available | LogP | 3.4 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Dexbrompheniramine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4i-9050000000-d51445063b50de15bdcc | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Dexbrompheniramine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Dexbrompheniramine LC-ESI-qTof , Positive-QTOF | splash10-0292-0940000000-f369442eba5344b3ecb4 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dexbrompheniramine , positive-QTOF | splash10-0292-0940000000-f369442eba5344b3ecb4 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Dexbrompheniramine 35V, Positive-QTOF | splash10-00di-0390000000-82ba7f6766f236ef3604 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexbrompheniramine 10V, Positive-QTOF | splash10-014i-0029000000-fa060b2610f05fd6963a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexbrompheniramine 20V, Positive-QTOF | splash10-01b9-0197000000-90a5b62f5a9e47f95802 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexbrompheniramine 40V, Positive-QTOF | splash10-0fef-3690000000-914dbc7e9fc6b1ce196a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexbrompheniramine 10V, Negative-QTOF | splash10-014i-0009000000-1bc9f3a3603646c31504 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexbrompheniramine 20V, Negative-QTOF | splash10-014i-1019000000-14a32020bd62ee6fb3b7 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexbrompheniramine 40V, Negative-QTOF | splash10-0fi4-7591000000-cd391d2ec4970c9e8b8a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexbrompheniramine 10V, Negative-QTOF | splash10-014i-0009000000-615031c9863c28108e0f | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexbrompheniramine 20V, Negative-QTOF | splash10-016r-6369000000-b40c997a38a0f9eb2fdb | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexbrompheniramine 40V, Negative-QTOF | splash10-004j-9480000000-6c5bc7bd482fbd292a0c | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexbrompheniramine 10V, Positive-QTOF | splash10-00di-0094000000-c8e61a4d45703ee2c906 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexbrompheniramine 20V, Positive-QTOF | splash10-00di-0090000000-363f1320fc00a31daef8 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Dexbrompheniramine 40V, Positive-QTOF | splash10-006t-1290000000-3b9b35511af51a9e3bb5 | 2021-09-23 | Wishart Lab | View Spectrum |
|
---|